Fineotex Chemical Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 9:30 pm

Market Cap	3,044 Cr.
Current Price	266
High / Low	439/192
Stock P/E	28.1
Book Value	63.8
Dividend Yield	0.60 %
ROCE	23.8 %
ROE	18.4 %
Face Value	2.00
PEG Ratio	1.27

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Fineotex Chemical Ltd

Competitors of Fineotex Chemical Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
HP Adhesives Ltd	490 Cr.	53.1	108/42.6	27.5	20.0	0.57 %	13.9 %	10.1 %	2.00
Haryana Leather Chemicals Ltd	35.3 Cr.	71.9	124/62.6	15.3	87.4	1.39 %	8.04 %	5.47 %	10.0
Hardcastle & Waud Mfg Co Ltd	50.7 Cr.	746	1,355/600	39.3	670	0.00 %	6.20 %	2.87 %	10.0
Grauer & Weil (India) Ltd	3,731 Cr.	82.3	120/78.0	23.7	20.7	0.61 %	23.8 %	18.0 %	1.00
DMCC Speciality Chemicals Ltd	687 Cr.	276	453/241	31.9	91.1	0.36 %	14.6 %	9.87 %	10.0
Industry Average	12,859.00 Cr	813.99		52.64	158.55	0.38%	13.28%	25.57%	6.44

All Competitor Stocks of Fineotex Chemical Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	121	136	134	109	138	132	145	138	153	142	146	126	120
Expenses	100	110	109	81	105	101	107	98	115	107	109	92	99
Operating Profit	22	26	25	29	33	32	38	40	38	35	36	34	21
OPM %	18%	19%	19%	26%	24%	24%	26%	29%	25%	25%	25%	27%	18%
Other Income	0	1	2	2	2	4	4	5	4	5	7	5	8
Interest	0	0	0	0	0	0	0	0	1	0	0	0	0
Depreciation	1	1	1	1	1	1	1	1	2	2	2	3	2
Profit before tax	21	26	26	29	33	34	40	44	40	38	41	36	26
Tax %	18%	22%	21%	23%	22%	22%	22%	24%	24%	22%	21%	24%	24%
Net Profit	17	20	21	22	26	26	31	33	30	29	32	28	20
EPS in Rs	1.49	1.79	1.86	2.00	2.33	2.32	2.83	2.95	2.72	2.57	2.78	2.41	1.74

Last Updated: May 31, 2025, 9:17 am

Below is a detailed analysis of the quarterly data for Fineotex Chemical Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 120.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Dec 2024) to 120.00 Cr., marking a decrease of 6.00 Cr..
For Expenses, as of Mar 2025, the value is 99.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 92.00 Cr. (Dec 2024) to 99.00 Cr., marking an increase of 7.00 Cr..
For Operating Profit, as of Mar 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Dec 2024) to 21.00 Cr., marking a decrease of 13.00 Cr..
For OPM %, as of Mar 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 27.00% (Dec 2024) to 18.00%, marking a decrease of 9.00%.
For Other Income, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Dec 2024) to 8.00 Cr., marking an increase of 3.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Dec 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Dec 2024) to 26.00 Cr., marking a decrease of 10.00 Cr..
For Tax %, as of Mar 2025, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 24.00%.
For Net Profit, as of Mar 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Dec 2024) to 20.00 Cr., marking a decrease of 8.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 1.74. The value appears to be declining and may need further review. It has decreased from 2.41 (Dec 2024) to 1.74, marking a decrease of 0.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:20 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	96	87	102	110	127	141	182	196	219	368	517	569	567
Expenses	86	77	85	82	98	111	148	162	178	297	404	421	422
Operating Profit	10	9	16	28	29	30	34	35	41	71	113	148	144
OPM %	11%	11%	16%	26%	23%	21%	19%	18%	19%	19%	22%	26%	25%
Other Income	2	3	5	2	10	5	1	-11	17	6	7	17	21
Interest	1	0	0	0	0	1	1	1	1	1	1	1	1
Depreciation	0	0	0	1	1	1	1	1	1	3	4	6	9
Profit before tax	11	11	20	29	38	34	34	22	56	73	115	158	155
Tax %	27%	30%	28%	31%	24%	29%	28%	35%	20%	22%	22%	23%
Net Profit	8	8	15	20	29	24	24	14	45	57	90	121	120
EPS in Rs	0.63	0.58	1.15	1.56	2.32	2.04	2.02	1.18	3.85	4.98	7.97	10.82	10.48
Dividend Payout %	8%	9%	9%	13%	4%	10%	5%	4%	8%	8%	10%	15%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	87.50%	33.33%	45.00%	-17.24%	0.00%	-41.67%	221.43%	26.67%	57.89%	34.44%
Change in YoY Net Profit Growth (%)	0.00%	87.50%	-54.17%	11.67%	-62.24%	17.24%	-41.67%	263.10%	-194.76%	31.23%	-23.45%

Fineotex Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	18%
5 Years:	22%
3 Years:	13%
TTM:	-6%

Compounded Profit Growth
10 Years:	26%
5 Years:	40%
3 Years:	25%
TTM:	-10%

Stock Price CAGR
10 Years:	23%
5 Years:	59%
3 Years:	18%
1 Year:	-26%

Return on Equity
10 Years:	22%
5 Years:	24%
3 Years:	24%
Last Year:	18%

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:31 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	11	22	22	22	22	22	22	22	22	22	22	23
Reserves	54	54	69	90	113	137	147	187	240	327	425	708
Borrowings	4	2	3	1	5	2	3	3	2	7	5	0
Other Liabilities	19	23	20	26	21	34	35	54	75	67	96	83
Total Liabilities	88	101	114	140	161	195	208	267	339	423	548	815
Fixed Assets	14	18	19	27	29	36	41	59	84	99	141	179
CWIP	0	0	0	0	0	0	1	5	0	0	0	21
Investments	16	29	39	47	55	48	52	32	17	89	147	330
Other Assets	58	54	56	66	77	110	114	171	238	234	260	284
Total Assets	88	101	114	140	161	195	208	267	339	423	548	815

Below is a detailed analysis of the balance sheet data for Fineotex Chemical Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 1.00 Cr..
For Reserves, as of Mar 2025, the value is 708.00 Cr.. The value appears strong and on an upward trend. It has increased from 425.00 Cr. (Mar 2024) to 708.00 Cr., marking an increase of 283.00 Cr..
For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 5.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 83.00 Cr.. The value appears to be improving (decreasing). It has decreased from 96.00 Cr. (Mar 2024) to 83.00 Cr., marking a decrease of 13.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 815.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 548.00 Cr. (Mar 2024) to 815.00 Cr., marking an increase of 267.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 179.00 Cr.. The value appears strong and on an upward trend. It has increased from 141.00 Cr. (Mar 2024) to 179.00 Cr., marking an increase of 38.00 Cr..
For CWIP, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 21.00 Cr., marking an increase of 21.00 Cr..
For Investments, as of Mar 2025, the value is 330.00 Cr.. The value appears strong and on an upward trend. It has increased from 147.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 183.00 Cr..
For Other Assets, as of Mar 2025, the value is 284.00 Cr.. The value appears strong and on an upward trend. It has increased from 260.00 Cr. (Mar 2024) to 284.00 Cr., marking an increase of 24.00 Cr..
For Total Assets, as of Mar 2025, the value is 815.00 Cr.. The value appears strong and on an upward trend. It has increased from 548.00 Cr. (Mar 2024) to 815.00 Cr., marking an increase of 267.00 Cr..

Notably, the Reserves (708.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	1	14	14	19	6	12	28	9	13	107	97	69
Cash from Investing Activity +	12	-14	-13	-14	-6	5	-19	-7	1	-99	-47	-273
Cash from Financing Activity +	-4	-3	-1	-6	-4	-3	-4	-4	-6	-6	-24	176
Net Cash Flow	9	-3	-1	-1	-3	14	6	-2	8	1	26	-27

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	10.00	5.00	14.00	25.00	28.00	25.00	32.00	32.00	38.00	69.00	106.00	143.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	64	92	80	84	84	72	98	100	138	110	72	89
Inventory Days	59	68	56	66	70	97	84	66	79	98	53	55
Days Payable	68	81	75	75	82	50	70	73	101	96	53	79
Cash Conversion Cycle	55	79	60	75	72	119	112	93	116	111	72	64
Working Capital Days	48	80	61	83	76	125	122	112	142	126	76	79
ROCE %	17%	15%	21%	31%	35%	26%	22%	20%	28%	30%	36%	39%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	64.82%	64.82%	64.94%	64.97%	65.00%	65.04%	65.04%	65.04%	65.04%	65.03%	64.46%	62.88%
FIIs	0.60%	0.25%	0.04%	1.02%	0.72%	0.71%	0.75%	0.72%	0.82%	1.45%	0.92%	3.28%
DIIs	6.15%	6.15%	5.35%	4.01%	3.65%	3.65%	3.65%	3.86%	3.69%	3.70%	3.68%	3.63%
Public	28.43%	28.78%	29.67%	29.99%	30.64%	30.62%	30.56%	30.39%	30.46%	29.83%	30.93%	30.20%
No. of Shareholders	63,047	64,851	72,146	1,05,710	1,10,855	1,10,312	1,13,469	1,16,801	1,16,067	1,22,095	1,26,673	1,28,268

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Small Cap Fund	4,041,828	0.32	120.35	4,041,828	2025-04-22 17:25:36	0%
Motilal Oswal Nifty Microcap 250 Index Fund	38,440	0.25	1.14	38,440	2025-04-22 17:25:36	0%
Groww Nifty Total Market Index Fund	89	0.01	0	89	2025-04-22 17:25:36	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	10.82	7.97	4.97	3.84	1.17
Diluted EPS (Rs.)	10.82	7.97	4.97	3.84	1.17
Cash EPS (Rs.)	11.47	8.47	5.36	4.16	1.39
Book Value[Excl.RevalReserv]/Share (Rs.)	40.95	32.12	24.32	19.51	15.81
Book Value[Incl.RevalReserv]/Share (Rs.)	40.95	32.12	24.32	19.51	15.81
Revenue From Operations / Share (Rs.)	51.37	46.68	33.25	19.73	17.64
PBDIT / Share (Rs.)	14.89	10.83	6.93	5.24	3.27
PBIT / Share (Rs.)	14.35	10.44	6.70	5.11	3.16
PBT / Share (Rs.)	14.23	10.37	6.62	5.04	1.97
Net Profit / Share (Rs.)	10.93	8.09	5.14	4.02	1.29
NP After MI And SOA / Share (Rs.)	10.82	7.97	4.98	3.85	1.17
PBDIT Margin (%)	28.98	23.19	20.83	26.57	18.53
PBIT Margin (%)	27.92	22.36	20.15	25.89	17.94
PBT Margin (%)	27.69	22.20	19.90	25.56	11.18
Net Profit Margin (%)	21.27	17.32	15.44	20.39	7.28
NP After MI And SOA Margin (%)	21.05	17.08	14.98	19.49	6.66
Return on Networth / Equity (%)	26.79	25.32	21.04	20.34	7.70
Return on Capital Employeed (%)	34.63	32.21	27.34	26.03	19.95
Return On Assets (%)	21.85	20.89	16.25	15.94	6.29
Total Debt / Equity (X)	0.01	0.02	0.01	0.01	0.01
Asset Turnover Ratio (%)	1.17	1.36	1.21	0.61	0.70
Current Ratio (X)	3.20	3.51	3.41	3.30	3.68
Quick Ratio (X)	2.64	2.77	2.53	2.72	3.01
Inventory Turnover Ratio (X)	6.98	6.37	4.92	3.46	4.03
Dividend Payout Ratio (NP) (%)	18.48	5.01	6.02	0.00	4.25
Dividend Payout Ratio (CP) (%)	17.60	4.78	5.75	0.00	3.90
Earning Retention Ratio (%)	81.52	94.99	93.98	0.00	95.75
Cash Earning Retention Ratio (%)	82.40	95.22	94.25	0.00	96.10
Interest Coverage Ratio (X)	123.87	146.13	83.11	80.21	57.75
Interest Coverage Ratio (Post Tax) (X)	91.90	110.15	62.62	62.55	43.75
Enterprise Value (Cr.)	4052.88	2534.05	1965.68	704.98	155.93
EV / Net Operating Revenue (X)	7.12	4.90	5.34	3.23	0.79
EV / EBITDA (X)	24.57	21.13	25.62	12.14	4.28
MarketCap / Net Operating Revenue (X)	7.17	4.99	5.42	3.34	0.83
Retention Ratios (%)	81.51	94.98	93.97	0.00	95.74
Price / BV (X)	9.13	7.40	7.61	3.48	0.97
Price / Net Operating Revenue (X)	7.17	4.99	5.42	3.34	0.83
EarningsYield	0.02	0.03	0.02	0.05	0.07

After reviewing the key financial ratios for Fineotex Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 10.82. This value is within the healthy range. It has increased from 7.97 (Mar 23) to 10.82, marking an increase of 2.85.
For Diluted EPS (Rs.), as of Mar 24, the value is 10.82. This value is within the healthy range. It has increased from 7.97 (Mar 23) to 10.82, marking an increase of 2.85.
For Cash EPS (Rs.), as of Mar 24, the value is 11.47. This value is within the healthy range. It has increased from 8.47 (Mar 23) to 11.47, marking an increase of 3.00.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 40.95. It has increased from 32.12 (Mar 23) to 40.95, marking an increase of 8.83.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 40.95. It has increased from 32.12 (Mar 23) to 40.95, marking an increase of 8.83.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 51.37. It has increased from 46.68 (Mar 23) to 51.37, marking an increase of 4.69.
For PBDIT / Share (Rs.), as of Mar 24, the value is 14.89. This value is within the healthy range. It has increased from 10.83 (Mar 23) to 14.89, marking an increase of 4.06.
For PBIT / Share (Rs.), as of Mar 24, the value is 14.35. This value is within the healthy range. It has increased from 10.44 (Mar 23) to 14.35, marking an increase of 3.91.
For PBT / Share (Rs.), as of Mar 24, the value is 14.23. This value is within the healthy range. It has increased from 10.37 (Mar 23) to 14.23, marking an increase of 3.86.
For Net Profit / Share (Rs.), as of Mar 24, the value is 10.93. This value is within the healthy range. It has increased from 8.09 (Mar 23) to 10.93, marking an increase of 2.84.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.82. This value is within the healthy range. It has increased from 7.97 (Mar 23) to 10.82, marking an increase of 2.85.
For PBDIT Margin (%), as of Mar 24, the value is 28.98. This value is within the healthy range. It has increased from 23.19 (Mar 23) to 28.98, marking an increase of 5.79.
For PBIT Margin (%), as of Mar 24, the value is 27.92. This value exceeds the healthy maximum of 20. It has increased from 22.36 (Mar 23) to 27.92, marking an increase of 5.56.
For PBT Margin (%), as of Mar 24, the value is 27.69. This value is within the healthy range. It has increased from 22.20 (Mar 23) to 27.69, marking an increase of 5.49.
For Net Profit Margin (%), as of Mar 24, the value is 21.27. This value exceeds the healthy maximum of 10. It has increased from 17.32 (Mar 23) to 21.27, marking an increase of 3.95.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 21.05. This value exceeds the healthy maximum of 20. It has increased from 17.08 (Mar 23) to 21.05, marking an increase of 3.97.
For Return on Networth / Equity (%), as of Mar 24, the value is 26.79. This value is within the healthy range. It has increased from 25.32 (Mar 23) to 26.79, marking an increase of 1.47.
For Return on Capital Employeed (%), as of Mar 24, the value is 34.63. This value is within the healthy range. It has increased from 32.21 (Mar 23) to 34.63, marking an increase of 2.42.
For Return On Assets (%), as of Mar 24, the value is 21.85. This value is within the healthy range. It has increased from 20.89 (Mar 23) to 21.85, marking an increase of 0.96.
For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.17. It has decreased from 1.36 (Mar 23) to 1.17, marking a decrease of 0.19.
For Current Ratio (X), as of Mar 24, the value is 3.20. This value exceeds the healthy maximum of 3. It has decreased from 3.51 (Mar 23) to 3.20, marking a decrease of 0.31.
For Quick Ratio (X), as of Mar 24, the value is 2.64. This value exceeds the healthy maximum of 2. It has decreased from 2.77 (Mar 23) to 2.64, marking a decrease of 0.13.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.98. This value is within the healthy range. It has increased from 6.37 (Mar 23) to 6.98, marking an increase of 0.61.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 18.48. This value is below the healthy minimum of 20. It has increased from 5.01 (Mar 23) to 18.48, marking an increase of 13.47.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 17.60. This value is below the healthy minimum of 20. It has increased from 4.78 (Mar 23) to 17.60, marking an increase of 12.82.
For Earning Retention Ratio (%), as of Mar 24, the value is 81.52. This value exceeds the healthy maximum of 70. It has decreased from 94.99 (Mar 23) to 81.52, marking a decrease of 13.47.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 82.40. This value exceeds the healthy maximum of 70. It has decreased from 95.22 (Mar 23) to 82.40, marking a decrease of 12.82.
For Interest Coverage Ratio (X), as of Mar 24, the value is 123.87. This value is within the healthy range. It has decreased from 146.13 (Mar 23) to 123.87, marking a decrease of 22.26.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 91.90. This value is within the healthy range. It has decreased from 110.15 (Mar 23) to 91.90, marking a decrease of 18.25.
For Enterprise Value (Cr.), as of Mar 24, the value is 4,052.88. It has increased from 2,534.05 (Mar 23) to 4,052.88, marking an increase of 1,518.83.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 7.12. This value exceeds the healthy maximum of 3. It has increased from 4.90 (Mar 23) to 7.12, marking an increase of 2.22.
For EV / EBITDA (X), as of Mar 24, the value is 24.57. This value exceeds the healthy maximum of 15. It has increased from 21.13 (Mar 23) to 24.57, marking an increase of 3.44.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 7.17. This value exceeds the healthy maximum of 3. It has increased from 4.99 (Mar 23) to 7.17, marking an increase of 2.18.
For Retention Ratios (%), as of Mar 24, the value is 81.51. This value exceeds the healthy maximum of 70. It has decreased from 94.98 (Mar 23) to 81.51, marking a decrease of 13.47.
For Price / BV (X), as of Mar 24, the value is 9.13. This value exceeds the healthy maximum of 3. It has increased from 7.40 (Mar 23) to 9.13, marking an increase of 1.73.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 7.17. This value exceeds the healthy maximum of 3. It has increased from 4.99 (Mar 23) to 7.17, marking an increase of 2.18.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Fineotex Chemical Ltd as of June 13, 2025 is: 265.48

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 13, 2025, Fineotex Chemical Ltd is Overvalued by 0.20% compared to the current share price 266.00

Intrinsic Value of Fineotex Chemical Ltd as of June 13, 2025 is: 324.35

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 13, 2025, Fineotex Chemical Ltd is Undervalued by 21.94% compared to the current share price 266.00

Last 5 Year EPS CAGR: 22.17%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 26.67%, which is a positive sign. The company has higher reserves (212.58 cr) compared to borrowings (3.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (252.38 cr) and profit (58.15 cr) over the years.	The stock has a high average Working Capital Days of 94.17, which may not be favorable. The stock has a high average Cash Conversion Cycle of 85.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fineotex Chemical Ltd:
1. Net Profit Margin: 21.27%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 34.63% (Industry Average ROCE: 13.28%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 26.79% (Industry Average ROE: 25.57%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 91.9
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.64
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 28.1 (Industry average Stock P/E: 52.64)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Fineotex Chemical Ltd. is a Public Limited Listed company incorporated on 30/01/2004 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH2004PLC144295 and registration number is 144295. Currently Company is involved in the business activities of Manufacture of chemicals and chemical products. Company's Total Operating Revenue is Rs. 439.22 Cr. and Equity Capital is Rs. 22.92 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Speciality - Others	42 & 43, Manorama Chambers, Mumbai Maharashtra 400050	investor.relations@fineotex.com http://www.fineotex.com

Management
Name	Position Held
Mr. Surendrakumar Tibrewala	Chairman & Managing Director
Mr. Sanjay Tibrewala	Executive Director & CFO
Mrs. Aarti Jhunjhunwala	Executive Director
Mrs. Bindu Shah	Independent Director
Dr. Sunil Waghmare	Independent Director
Mr. Alok Dhanuka	Independent Director
Mr. Navin Mittal	Independent Director

FAQ

What is the intrinsic value of Fineotex Chemical Ltd?

Fineotex Chemical Ltd's intrinsic value (as of 13 June 2025) is ₹265.48 — 0.20% lower the current market price of 266.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,044 Cr. market cap, FY2025-2026 high/low of ₹439/192, reserves of 708 Cr, and liabilities of 815 Cr.

What is the Market Cap of Fineotex Chemical Ltd?

The Market Cap of Fineotex Chemical Ltd is 3,044 Cr..

What is the current Stock Price of Fineotex Chemical Ltd as on 13 June 2025?

The current stock price of Fineotex Chemical Ltd as on 13 June 2025 is 266.

What is the High / Low of Fineotex Chemical Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Fineotex Chemical Ltd stocks is ₹439/192.

What is the Stock P/E of Fineotex Chemical Ltd?

The Stock P/E of Fineotex Chemical Ltd is 28.1.

What is the Book Value of Fineotex Chemical Ltd?

The Book Value of Fineotex Chemical Ltd is 63.8.

What is the Dividend Yield of Fineotex Chemical Ltd?

The Dividend Yield of Fineotex Chemical Ltd is 0.60 %.

What is the ROCE of Fineotex Chemical Ltd?

The ROCE of Fineotex Chemical Ltd is 23.8 %.

What is the ROE of Fineotex Chemical Ltd?

The ROE of Fineotex Chemical Ltd is 18.4 %.

What is the Face Value of Fineotex Chemical Ltd?

The Face Value of Fineotex Chemical Ltd is 2.00.